A bacterial strain combined with immunotherapy doubled the median overall survival of mice with prostate cancer, according to a Northwestern University study published in the journal Nature Communications. The bacteria, named CP1, was isolated from a patient with benign prostate pain.
Bacteria plus immunotherapy shows promise in prostate cancer treatment
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.